Cyxone in media

Cyxone in media

BioStock article: Cyxone’s CRO agreement signal phase IIb RA trial is moving forward as planned

Dec 20, 2021

BioStock published an article on 20 December 2021 about Cyxone, which can be read in full below. In the preparation for the coming phase IIb trial with Rabeximod in rheumatoid arthritis, biotech company Cyxone has entered an Early Operations...

Read More

BioStock article: Pre-clinical data indicates wider use for Cyxone’s T20K in MS

Nov 8, 2021

BioStock published an article on 8 November 2021 about Cyxone, which can be read in full below. Biotech company Cyxone is developing T20K, a drug candidate with first-in-class potential for the treatment of multiple sclerosis. Recently, Cyxone’s research partner,...

Read More

BioStock article: Eight CEOs on their expectations at BIO-Europe

Oct 25, 2021

It is time for 2021’s edition of the largest partnering meeting in the life science space – BIO-Europe. This week, representatives from nearly 1,500 companies will gather to establish new contacts as well as continue initiated discussions with potential...

Read More

BioStock article: Cyxone has closed recruitment to the phase II Covid-19 trial

Aug 16, 2021

BioStock published an article on 16 August 2021 about Cyxone, which can be read in full below. Swedish biotech Cyxone announced last month that the patient recruitment for its phase II trial testing Rabeximod in Covid-19 could come to...

Read More

BioStock article: Cyxone is exploring new treatment possibilities for T20K

Jul 15, 2021

BioStock published an article on 15 July 2021 about Cyxone, which can be read in full below. After identifying new therapeutic treatment possibilities for T20K, Cyxone has announced a research collaboration with the Medical University of Vienna to further...

Read More

BioStock article: New COO brings extensive immunology experience to Cyxone

Jun 14, 2021

BioStock published an article on 14 June 2021 about Cyxone, which can be read in full below. During May, Swedish biotech company Cyxone released a string of news. Recently, the company announced the recruitment of Carl-Magnus Högerkorp as new...

Read More

BioStock article: Spotlight on MS

May 28, 2021

BioStock published an article on 28 May 2021 about Cyxone, which can be read in full below. World MS Day will be celebrated on Sunday May 30th. It is a day to raise awareness of the condition, and to...

Read More

BioStock article: Cyxones expands possibilities for T20K in MS

May 20, 2021

BioStock published an article on 20 May 2021 about Cyxone, which can be read in full below. Recently, Malmö-based company Cyxone, announced the next development steps for its drug candidate T20K for the treatment of multiple sclerosis. A process...

Read More

BioStock article: Cyxone joins forces with leading rheumatoid arthritis expert

May 18, 2021

BioStock published an article on 18 May 2021 about Cyxone, which can be read in full below. Biotech company Cyxone is in the process of preparing drug candidate Rabeximod for the next clinical stage. Recently, the company announced a...

Read More

Labiotech: The Rollercoaster of Repurposing an Arthritis Drug for Covid-19

May 10, 2021

Read the article with CEO Tara Heitner and COO Malin Berthold telling the story how Cyxone initiated the Covid-19 trial. Read the article here.

Read More